Classification
- Anatomical main groupCCardiovascular system
- Therapeutic subgroupC01
- Pharmacological subgroupC01E
- Chemical subgroupC01EB
- Chemical substanceC01EB21Regadenoson
Where it is registered
Each register and historical list with its number of registrations and a few of them.
United States
FDA · 2 registrations
Spain
AEMPS · 1 registration
European Union
EMA · 1 registration
Croatia
HALMED · 1 registration
Netherlands
CBG-MEB · 1 registration
At a glance
- ATC code
- C01EB21
- ATC group
- Cardiovascular system
- Registers
- 5
- Historical lists
- 1
- Registrations
- 7
- With their own page
- 6
- Companies
- 5
All medicines with Regadenoson
Human medicines from every register that match Regadenoson by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
7 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Regadenoson | United States | 0.4MG/5ML | solution | Marketed | Accord Hlthcare |
| Lexiscan | United States | 0.4MG/5ML | solution | Marketed | Astellas |
| Rapiscan | European Union | Authorised | GE Healthcare AS | ||
| Rapiscan 400mcg solucion inyectable | Spain | 400 µg | solución inyectable | Marketed | Ge Healthcare As |
| Rapiscan 400 microgram oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | GE Healthcare AS | |
| Rapiscan | Croatia | Marketed | |||
| RAPISCAN 400 micrograme | Romania | 80 micrograme/ml | sol. inj. | Status unknown | Ge Healthcare As |